Zobrazeno 1 - 10
of 34
pro vyhledávání: '"R T, Steigbigel"'
Autor:
Daniel R. Kuritzkes, Sharon Safrin, R T Steigbigel, T C Bailey, S Owens, G F McKinley, Thomas Nevin, Joyce A. Korvick, Constance A. Benson, Judith Feinberg, S H Cheeseman, S Hurwitz, C Farthing, B Wettlaufer, Harold A. Kessler
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12:147-152
SUMMARY Twenty-six AIDS patients were enrolled in an open label pilot study to evaluate the efficacy and toxicity of topical 1 percent ophthalmic trifluridine solution for the treatment of chronic mucocutaneous herpes simplex virus disease unresponsi
Autor:
M A, McNurlan, P J, Garlick, R A, Frost, K A, Decristofaro, C H, Lang, R T, Steigbigel, J, Fuhrer, M, Gelato
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(9)
Loss of lean tissue often accompanies human immunodeficiency virus (HIV) infection. Exogenous human recombinant GH (hrGH) has been shown to be beneficial in reversing this wasting. However, catabolic effects of hrGH on muscle protein metabolism have
Autor:
Lori J. Gabryelski, H L Robbins, D Laird, Donald J. Graham, R T Steigbigel, Daniel J. Holder, J A Chodakewitz, Malathi Shivaprakash, O M Blahy, F. E. Massari, Jon H. Condra, Robert M. Danovich, T Yang, Elizabeth Roth, Quintero Julio C, A Rhodes, William A. Schleif, Emilio A. Emini, K E Squires, Deutsch Paul J, Randi Y. Leavitt, J W Mellors, Hedy Teppler
Indinavir (IDV) (also called CRIXIVAN, MK-639, or L-735,524) is a potent and selective inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease. During early clinical trials, in which patients initiated therapy with suboptimal dosages of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7b97919b851dd2170bcead88bfc7e3
https://europepmc.org/articles/PMC190914/
https://europepmc.org/articles/PMC190914/
Publikováno v:
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 44(10)
The purpose of this study was to determine the in situ distribution of PCR-amplified HIV-1 and EBV DNA in hyperplastic lymph nodes and in AIDS-related lymphomas. PCR amplified HIV-1 DNA was detected, on average, in about 30% and 20% of the CD4 and CD
Publikováno v:
Digestive diseases and sciences. 41(7)
The mechanisms underlying acid secretory failure in patients with HIV disease are unknown. We evaluated, in a series of preliminary studies, changes associated with parietal cell structure and function in early and late HIV disease, in an attempt to
Urokinase-type plasminogen activator (uPA), a proteinase which activates plasminogen by cleaving at -CPGR(arrow downward)V-, was shown to cleave the V3 loop in recombinant gp120 of human immunodeficiency virus type 1 (HIV-1) IIIB and MN strains, as w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e84b94cc3e62f409273fe19122cfe88d
https://europepmc.org/articles/PMC190379/
https://europepmc.org/articles/PMC190379/
Autor:
H A, Kessler, S, Hurwitz, C, Farthing, C A, Benson, J, Feinberg, D R, Kuritzkes, T C, Bailey, S, Safrin, R T, Steigbigel, S H, Cheeseman, G F, McKinley, B, Wettlaufer, S, Owens, T, Nevin, J A, Korvick
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 12(2)
Twenty-six AIDS patients were enrolled in an open label pilot study to evaluate the efficacy and toxicity of topical 1 percent ophthalmic trifluridine solution for the treatment of chronic mucocutaneous herpes simplex virus disease unresponsive to at
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 11(4)
To assess safety, antitumor response, and immunological and virological activity of interferon-alpha 2a and zidovudine combination therapy in patients with AIDS-related Kaposi's sarcoma, we conducted an open-label, Phase II, multicenter study. Sixty-
Autor:
J J, Pollock, R P, Santarpia, H M, Heller, L, Xu, K, Lal, J, Fuhrer, H W, Kaufman, R T, Steigbigel
Publikováno v:
Journal of acquired immune deficiency syndromes. 5(6)
This investigation compared the salivary anticandidal activities of 12 healthy adults with 12 hospitalized patients with AIDS. Stimulated parotid, submandibular-sublingual, and whole salivas were collected during a period of 10 min, immediately acidi